Actuate Therapeutics ACTU
NASDAQ ACTU
$0.30 -0.02 (-5.32%)
At close: Nov 10, 2026 · 4:00 PM EST

Actuate Therapeutics (ACTU) EPS (Diluted) (2023 - 2026)

Updated

Actuate Therapeutics' EPS (Diluted) came in at -$0.20 for Q2 2026, compared with -$0.30 a year earlier.

Analysis

Actuate Therapeutics (ACTU) EPS (Diluted) (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Actuate Therapeutics reported EPS (Diluted) of -$0.87; for FY2025, it was -$1.06.

  • Going back by year, EPS (Diluted) was -$3.26 in FY2024 and -$17.24 in FY2023.
  • The Q2 2026 figure represents the highest quarterly EPS (Diluted) in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 7.22
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.09
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 2.38
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 2.04
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.67
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 1.60
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 7.08
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 1.94
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.56
10 Actuate Therapeutics 7.56 Mn -35.08 Mn - -0.20
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.20
Dec 31, 2025 -0.22
Sep 30, 2025 -0.25
Jun 30, 2025 -0.30
Mar 31, 2025 -0.32
Dec 31, 2024 -0.77
Sep 30, 2024 -0.55
Jun 30, 2024 -4.20
Mar 31, 2024 -5.40
Dec 31, 2023 -5.30
Sep 30, 2023 -4.31
Jun 30, 2023 -3.88
API Access

Actuate Therapeutics EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=ACTU&period=max&api_key=YOUR_API_KEY